Phenotype Annotations Click to see Annotation Detail View
Mammalian PhenotypeTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | decreased circulating HDL cholesterol level | | IAGP | | 150429989 | | RGD | | decreased circulating insulin level | | IAGP | | 150429989 | | RGD | | decreased circulating LDL cholesterol level | | IAGP | | 150429989 | | RGD | | decreased epididymal fat pad weight | | IAGP | | 150429989 | | RGD | | decreased fasting circulating glucose level | induces | IAGP | XCO:0000275,XCO:0000444 | 150429989; 150429989 | | RGD | | decreased glutathione level | | IAGP | | 150429989; 150429989 | | RGD | | decreased glutathione peroxidase activity | | IAGP | | 150429989 | | RGD | | decreased glutathione reductase level | | IAGP | | 150429989 | | RGD | | decreased superoxide dismutase level | | IAGP | | 150429989; 150429989 | | RGD | | hyperchylomicronemia | | IAGP | | 150429989 | | RGD | | increased catalase level | | IAGP | | 150429989 | | RGD | | increased circulating CCL3 level | | IAGP | | 150429989 | | RGD | | increased circulating insulin level | | IAGP | | 150429989 | | RGD | | increased circulating interleukin-17 level | | IAGP | | 150429989 | | RGD | | increased circulating triglyceride level | | IAGP | | 150429989 | | RGD | | increased circulating tumor necrosis factor level | | IAGP | | 150429989 | | RGD | | increased epididymal fat pad weight | | IAGP | | 150429989 | | RGD | | increased interleukin-12 secretion | | IAGP | | 150429989 | | RGD | | increased interleukin-18 secretion | | IAGP | | 150429989 | | RGD | | increased interleukin-6 secretion | | IAGP | | 150429989 | | RGD | | |